The JP Morgan Healthcare conference is the flagship global investment focused event and marked its 40th year in January 2022 with a virtual event. Typically, the hot topics from JP Morgan set the tone for the life science community for the rest of the year. In this short round up, we will summarise some of the key themes and ‘mood music’ emerging from the conference that have been reported by the industry press.
PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.
Over the last two years, as a whole society and within the pharmaceutical community specifically, we have been forced to adapt and change at an unprecedented scale and speed. While we certainly hope that 2022 will represent less disruption and more recovery, we expect a continued climate of change. In this article Dr Malcolm Barratt-Johnson outlines some of the key trends set to shape the industry in 2022.
Many thanks to LBIC and Lucy Garnsworthy for featuring PharmaMedic’s insights on recent UK government initiatives to support pharma and medicaldevices regulatory innovation in its winter newsletter. The article features on page 6 of the newsletter.
The petrol shortages earlier this quarter disrupted the country and impacted supply and distribution channels across sectors. In this new article we discuss issues affecting our vital UK pharmaceutical supply chain and the ways in which organisations can build resilience.
We enjoyed a very engaging session for our latest virtual breakfast briefing examining the UK's role in the international life sciences community from innovation and regulatory perspectives. If you missed the event, or would like to recap the key takeaways, read our summary, and catch up with the recording here.
A life working as a consultant in the pharmaceutical industry offers substantial benefits, including flexibility and varied work. While consultants may not experience the defined career pathway we follow as an employee, we can still steer our professional journeys through mentorship, training, and networking. Read more to learn how.
PharmaMedic is delighted to announce our next virtual event on Thursday 28th October 2021 at 8 am. As the UK life sciences sector continues its journey outside the EU, it’s time to forge a new role in the international community. This briefing will highlight some of the critical considerations we face from both innovation and regulatory perspectives. Learn more about the agenda and register here.
With the government, the MHRA has launched a new consultation to shape a new era of medical device regulation in the UK. The objective is to create a framework that improves patient and public safety, increases transparency in regulatory decision-making, and aligns with global best practices. In this article, we summarise the issues and the scope of the potential changes.
In June, the government published a comprehensive report by the Taskforce on Innovation, Growth and Regulatory reform. The Prime Minister commissioned the taskforce, led by Rt Hon Sir Iain Duncan Smith MP, Rt Hon Theresa Villiers MP, and George Freeman MP, to review the UK's overall approach to regulation following Brexit. The taskforce examined the opportunities of regulatory independence in supporting cross-sector innovation. In this new article, we summarise some of the headline proposals.
